Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
|
Merck & Co., Inc. (MRK)
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/02/2021 | Organon & Co. | | Other (disposition) | Common Stock | 253.5M | $0.00 | $0 | | 06/02/2021 |
| 04/08/2019 | NGM BIOPHARMACEUTICALS INC | NGM | Purchase | Common Stock | 4.1M | $16.00 | $65.9M | See Footnote | 04/08/2019 |
| 04/08/2019 | NGM BIOPHARMACEUTICALS INC | NGM | Conversion | Common Stock | 8.8M | $0.00 | $0 | See Footnote | 04/08/2019 |
| 04/08/2019 | NGM BIOPHARMACEUTICALS INC | NGM | Conversion | Series E Convertible Preferred Stock | 17.7M | $0.00 | $0 | See Footnote | 04/08/2019 |
| 10/01/2018 | SUTRO BIOPHARMA, INC. | STRO | Conversion | Series E Redeemable Convertible Preferred Stock | 74.8M | $0.00 | $0 | See Footnote | 10/01/2018 |
| 10/01/2018 | SUTRO BIOPHARMA, INC. | STRO | Purchase | Common Stock | 666.7k | $15.00 | $10M | See Footnote | 10/01/2018 |
| 10/01/2018 | SUTRO BIOPHARMA, INC. | STRO | Conversion | Common Stock | 2.1M | $0.00 | $0 | See Footnote | 10/01/2018 |
| 06/27/2016 | OPGEN INC | OPGN | Purchase | Warrants | 2.1M | $1.31 | $2.7M | See Footnote | 06/27/2016 |
| 06/27/2016 | OPGEN INC | OPGN | Grant | Common Stock | 2.7M | $0.00 | $0 | See Footnote | 06/27/2016 |
| 05/19/2016 | OPGEN INC | OPGN | Grant | Common Stock | 1.2M | $0.00 | $0 | See Footnote | 05/19/2016 |
| 05/19/2016 | OPGEN INC | OPGN | Purchase | Warrants | 900k | $1.31 | $1.2M | See Footnote | 05/19/2016 |
| 05/19/2016 | OPGEN INC | OPGN | Purchase | Common Stock and Warrants (Obligation to buy Units) | 2.7M | $1.14 | $3.1M | See Footnote | 05/19/2016 |
| 02/08/2016 | BeiGene, Ltd. | BGNE | Conversion | Ordinary Shares | 18.5M | $0.00 | $0 | Via wholly owned subsidiary, MSDRG | 02/08/2016 |
| 02/08/2016 | BeiGene, Ltd. | BGNE | Other (acquisition) | Ordinary Shares | 7.9M | $0.00 | $0 | Via wholly owned subsidiary, MSDRG | 02/08/2016 |
| 02/08/2016 | BeiGene, Ltd. | BGNE | Conversion | Series A Preferred Shares | 18.5M | $0.00 | $0 | Via wholly owned subsidiary, MSDRG | 02/08/2016 |
| 02/08/2016 | BeiGene, Ltd. | BGNE | Conversion | | 5.1M | $0.00 | $0 | Via wholly owned subsidiary, MSDRG | 02/08/2016 |
| 02/08/2016 | BeiGene, Ltd. | BGNE | Conversion | Ordinary Shares | 5.1M | $0.00 | $0 | Via wholly owned subsidiary, MSDRG | 02/08/2016 |
|